Skip to main content
OpenTrials

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,069 public trials 1,362 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Recruiting

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

NCT04172532

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 44 locations
View Trial Details
Recruiting

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

NCT07524322

Conditions
Adnexal Diseases, Advanced Breast Cancer, Breast Cancer, +30 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • NEXT Houston Houston, Texas, United States
  • NEXT San Antonio San Antonio, Texas, United States
View Trial Details
Recruiting

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

NCT03564340

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +23 more
Locations
  • University of Alabama_6th Ave Birmingham, Alabama, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber / Harvard Cancer Center Boston, Massachusetts, United States
  • Mayo Clinic - Rochester Rochester, Minnesota, United States
View all 52 locations
View Trial Details
Recruiting

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

NCT06943755

Conditions
Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +19 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • Cedars-Sinai Medical Center Beverly Hills, California, United States
View all 117 locations
View Trial Details
Recruiting

A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma

NCT03334708

Conditions
Cysts, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All protocol activities) Montvale, New Jersey, United States
  • Cold Springs Harbor Laboratory (Specimen Analysis) Cold Spring Harbor, New York, United States
  • Memorial Sloan Kettering Cancer Center @ Commack (All Protocol Activities) Commack, New York, United States
View all 13 locations
View Trial Details
Recruiting

A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

NCT07306559

Conditions
Adnexal Diseases, Advanced Relapsed or Refractory Endometrial Cancer, Advanced Relapsed or Refractory Germ Cell Tumours, +18 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Indiana University Indianapolis, Indiana, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
View all 13 locations
View Trial Details
Recruiting

DESTINY-PANTUMOUR04

NCT07124000

Conditions
Adenocarcinoma, Adenocarcinoma (NOS), Adnexal Diseases, +116 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Bullhead City, Arizona, United States
  • Research Site Casa Grande, Arizona, United States
  • Research Site San Diego, California, United States
View all 18 locations
View Trial Details
Recruiting

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

NCT07090499

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, +50 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
View all 30 locations
View Trial Details
Recruiting

Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer

NCT05142189

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
Locations
  • University of Kentucky Chandler Medical Center Lexington, Kentucky, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Ohio State University Columbus, Ohio, United States
View all 45 locations
View Trial Details
Recruiting

Pancreatic Cancer Early Detection Consortium

NCT04970056

Conditions
Cysts, Digestive System Diseases, Digestive System Neoplasms, +16 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • Providence Health and Services Burbank, California, United States
  • City of Hope Duarte, California, United States
View all 60 locations
View Trial Details

Related conditions